Comparing 2L Bi-Pegyte to 4L PegLyte Regiments for Outpatient Colonic Preparation
- Conditions
- Efficacy of Bowel PreparationEase of Bowel Preparation and Patient Tolerability
- Interventions
- Drug: Standard Bowel PrepDrug: 2L Bi-Peglyte Bowel Prep
- Registration Number
- NCT01398020
- Lead Sponsor
- University of British Columbia
- Brief Summary
The investigators wish to compare the efficacy and patient tolerability of a preparation consisting of 2L Bi-Peglyte plus 15mg of bisacodyl vs the standard preparation of 4L Peglyte. The investigators hypothesize that 2L Bi-Peglyte with 15mg bisacodyl will show higher efficacy and tolerability.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 318
- Age 19 or older
- Outpatient colonoscopy
- constipation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard bowel prep Standard Bowel Prep Subject will receive standard bowel prep prior to colonoscopy. 2L Bi-Peglyte 2L Bi-Peglyte Bowel Prep Subjects will be asked to take 2L Bi-Peglyte + 15mg bisacodyl for bowel prep the day before colonoscopy.
- Primary Outcome Measures
Name Time Method Difference in Boston Bowel Preparation Scale between the two groups 30 minutes This is an established rating scale to evaluate the quality of bowel prep. The ratings will be compared between the two groups.
- Secondary Outcome Measures
Name Time Method Difference in the number of participants who develop distress symptoms from bowel prep (and the type) between the two groups 20 hours Number of participants who develop distress symptoms from bowel prep, and the type of distress symptoms will be compared between the two groups
Difference in the absolute number/percentage of participants in the two groups who find the bowel prep experience easy, acceptable, difficult, very difficult, or unable to complete. 20 Participants will be asked to rate their bowel prep experience (based on ease of use) on a Likert scale. The number of participants in each level will subsequently be quantified (n, %) and compared between the two groups.
Trial Locations
- Locations (1)
St. Paul's Hospital
🇨🇦Vancouver, British Columbia, Canada